Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells

Leukemia

Volumn 11, Issue 10, 1997, Pages 1700-1710

  Lanza, F ^a   Castagnari, B ^a   Rigolin, G ^a   Moretti, S ^a   Latorraca, A ^a   Ferrari, L ^a   Bardi, A ^a   Castoldi, G ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Acute myeloid leukemia; Flow cytometry; GM CSF; GM CSF receptor; Receptor modulation

Indexed keywords

CD34 ANTIGEN; CYTOKINE RECEPTOR; FLUOROCHROME; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; BONE MARROW; COLONY FORMING UNIT GM; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MONOCYTE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PRIORITY JOURNAL; PROMYELOCYTE; QUANTITATIVE ASSAY;

EID: 0030720232     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400794     Document Type: Article

References (14)

1. Gasson J. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 1991; 6: 1131-1145.
2. Lowenberg B, Touw IP. Haematopoietic growth factors and their receptor in acute leukemia. Blood 1993; 2: 281-292.
3. Lowenberg B, De Greef GE, Wielenga JJ. Granulocyte-macrophage colony-stimulating factor in the treatment of haematological malignancies. Anticancer Drugs 1993; 4: 17-20.
4. Baer MR, Bernstein SH, Brunetto VL, Heinonen K, Mròzek K, Swann VL, Minderman H, Block AMW, Pixley LA, Christiansen NP, Fay JW, Barcos M, Rustum Y, Herzig GP, Bloomfield CD. Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia. Blood 1996; 87: 1484-1494.
5. Lieschke GJ, Stanley E, Grail D, Hodgson G, Sinickas V, Gall JAM, Sinclair RA, Dunn AR. Mice lacking both macrophage and granulocyte-macrophage colony-stimulating factor have macrophages and co-existent osteopetrosis and severe lung disease. Blood 1994; 84: 27-32.
6. Estey EH, Dixon D, Kantarjian HM, Keating MJ, McCredie K, Bodey GP, Kurzrock R, Talpaz M, Freireich E, Deisseroth AB, Gutterman JU. Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with Ara-C and recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1990; 75: 1766-1769.
7. Buchner T, Hiddermann W, Koenigsmann M, Zuhlsdorf M, Wormann B, Boeckmann A, Freire E, Innig G, Mashmeyer G, Ludwig W, Sauerland M, Heinecke A, Shulz G. Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse, Blood 1991; 78: 1190-1197.
8. Baro CR, Bello-Fernandez C, Hermida G, Calavia H, Alsar MJ, Loyola A, Cuadrado MA, Iriondo A, Conde E, Zubizarreta A. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse. Bone Marrow Transplant 1995; 15: 721-726.
9. Stone RM, Berg DT, George SL, George S, Dodge R, Paciucci P, Schulman P, Lee E, Moore J, Powell B, Schiffer C. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. New Engl J Med 1995; 332: 1671-1677.
10. Heil G, Chadid L, Hoelzer D, Seipelt G, Mitrou P, Huber Ch, Kolbe K, Mertelsmann R, Lindemann A, Frisch J, Nicolay U, Gaus W, Heimpel H. GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia. Leukemia 1995; 9: 3-9.
11. Rowe JM, Andersen JW, Mazza JJ, Bennett J, Paietta E, Hayes A, Oette D, Cassileth P, Stadtmauer E, Wiernik P. A randomised placebo controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology group (E1490). Blood 1995; 86: 457-462.
12. Zittoun R, Mandelli F, de Witte T, Willemze R, Thaler J, Hayat M, Strickmans P, Peetermans M, Dardenne M, Solbu G, Suciu S. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) during induction treatment of acute myelogeneous leukemia (AML). A randomized trial from EORTC-GIMEMA cooperative groups. Blood 1994; 84: 231 (Abstr. 909).
13. Bassan R, Rambaldi A, Amaru R, Motta T, Barbui T. Unexpected remission of acute myeloid leukemia after GM-CSF. Br J Haematol 1994; 87: 835-838.
14. Visani G. Granulocyte-macrophage colony-stimulating factor in acute non lymphocytic leukemia before and after chemotherapy. Ann Haematol 1991; 63: 276-281.